Sitryx Therapeutics Revenue and Competitors

Oxford,

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Sitryx Therapeutics's estimated annual revenue is currently $9.5M per year.(i)
  • Sitryx Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • Sitryx Therapeutics has 61 Employees.(i)
  • Sitryx Therapeutics grew their employee count by -2% last year.

Sitryx Therapeutics's People

NameTitleEmail/Phone
1
CSOReveal Email/Phone
2
Head People & CultureReveal Email/Phone
3
Head Early Clinical DevelopmentReveal Email/Phone
4
Chief Scientific Officer at SitryxReveal Email/Phone
5
Chief Medical OfficerReveal Email/Phone
6
Associate Director FinanceReveal Email/Phone
7
Chief Financial OfficerReveal Email/Phone
8
Chief Business OfficerReveal Email/Phone
9
IT Project Manager / IT SupportReveal Email/Phone
10
Portfolio ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$1.3M170%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$4.2M27-7%N/AN/A
#10
$10.1M655%N/AN/A
Add Company

What Is Sitryx Therapeutics?

Sitryx is a biopharmaceutical company focused on regulating cell metabolism to develop first-in-class disease modifying therapeutics in immuno-oncology and immuno-inflammation. The company was co-founded by a team of world-leading scientists from the United States and Europe who have contributed significantly to the field of immunometabolism. Sitryx was founded in 2018 with seed funding from SV Health Investors and raised $30 million Series A funding from an international syndicate of specialist investors including SV Health Investors, Sofinnova Partners, Longwood Fund and GSK. The company has a pipeline of projects at multiple stages of drug discovery. Sitryx is headquartered in Oxford, UK.

keywords:N/A

N/A

Total Funding

61

Number of Employees

$9.5M

Revenue (est)

-2%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Sitryx Therapeutics News

2022-04-17 - Let's build something together: Ex-Lowe's CFO to join Pfizer ...

Eli Lilly immunometabolism partner Sitryx Therapeutics out of Oxford ... at Sobi before choosing a different path here at GSK-backed Sitryx.

2022-04-06 - Sitryx Therapeutics Strengthens Leadership Team With ...

Sitryx is a global biopharmaceutical company pioneering the field of immunometabolism. The company's proprietary platform and Product Engine are...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$11.5M6113%N/A
#2
$11.5M61-26%N/A
#3
$5.8M63-3%N/A
#4
$15.6M6439%N/A
#5
$9.8M6433%N/A